T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BSMX
351
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $286M | 0.06% |
31,289,051
+197,232
| +0.6% | +$1.98M |
|
352
TE Connectivity
TEL
$62.5B
| $286M | 0.06% |
4,440,606
+2,072,496
| +88% | +$143M |
|
353
Allegiant Air
ALGT
$2.38B
| $285M | 0.06% |
1,600,864
-776,870
| -33% | -$129M |
|
|
CB
354
DELISTED
CHUBB CORPORATION
CB
| $283M | 0.06% |
2,970,141
-322,344
| -10% | -$31.8M |
|
|
DGI
355
DELISTED
DigitalGlobe Inc.
DGI
| $282M | 0.06% |
10,157,833
-208,060
| -2% | -$6.57M |
|
356
Fastenal
FAST
$59B
| $281M | 0.06% |
26,672,948
+6,352,096
| +31% | +$66.8M |
|
357
Graco
GGG
$13.3B
| $281M | 0.06% |
11,862,933
+1,271,892
| +12% | +$30.7M |
|
|
EVHC
358
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $277M | 0.06% |
2,341,106
+13,326
| +0.6% | +$1.52M |
|
359
Aramark
ARMK
$16.2B
| $277M | 0.06% |
12,374,213
+1,381,883
| +13% | +$31.2M |
|
|
POT
360
DELISTED
Potash Corp Of Saskatchewan
POT
| $277M | 0.06% |
8,933,952
-168,941
| -2% | -$5.41M |
|
361
Boston Properties
BXP
$11.1B
| $277M | 0.06% |
2,285,289
+56,126
| +3% | +$7.39M |
|
362
Centene
CNC
$32.6B
| $275M | 0.06% |
6,851,810
-15,280
| -0.2% | -$549K |
|
363
Allstate
ALL
$65.6B
| $275M | 0.06% |
4,241,204
-1,033,247
| -20% | -$70.8M |
|
364
SBA Communications
SBAC
$19.8B
| $275M | 0.06% |
2,387,991
+499,977
| +26% | +$58.7M |
|
365
Flowers Foods
FLO
$1.6B
| $274M | 0.06% |
12,974,578
+276,046
| +2% | +$6.2M |
|
366
Harley-Davidson
HOG
$2.89B
| $274M | 0.06% |
4,857,286
-1,381,187
| -22% | -$79M |
|
367
Pacira BioSciences
PCRX
$925M
| $273M | 0.06% |
3,865,827
-450,394
| -10% | -$35.5M |
|
|
ATHN
368
DELISTED
Athenahealth, Inc.
ATHN
| $273M | 0.06% |
2,381,039
+398,467
| +20% | +$47.6M |
|
|
XLNX
369
DELISTED
Xilinx Inc
XLNX
| $272M | 0.06% |
6,160,522
-65,033
| -1% | -$2.93M |
|
370
C.H. Robinson
CHRW
$17.6B
| $270M | 0.06% |
4,330,935
+307,088
| +8% | +$20.2M |
|
371
Toro Company
TTC
$9.26B
| $270M | 0.06% |
7,963,260
-41,980
| -0.5% | -$1.44M |
|
372
Ally Financial
ALLY
$13.6B
| $270M | 0.06% |
12,024,253
+6,860
| +0.1% | +$151K |
|
373
Revvity
RVTY
$13.1B
| $267M | 0.05% |
5,074,456
+3,479,510
| +218% | +$181M |
|
374
Brunswick
BC
$5.3B
| $267M | 0.05% |
5,243,719
-456,139
| -8% | -$23.8M |
|
|
MON
375
DELISTED
Monsanto Co
MON
| $266M | 0.05% |
2,498,083
-115,308
| -4% | -$13.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.